Your browser doesn't support javascript.
loading
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Stirrup, Oliver; Boshier, Florencia; Venturini, Cristina; Guerra-Assunção, José Afonso; Alcolea-Medina, Adela; Beckett, Angela; Charalampous, Themoula; da Silva Filipe, Ana; Glaysher, Sharon; Khan, Tabassum; Kulasegaran Shylini, Raghavendran; Kele, Beatrix; Monahan, Irene; Mollett, Guy; Parker, Matthew; Pelosi, Emanuela; Randell, Paul; Roy, Sunando; Taylor, Joshua; Weller, Sophie; Wilson-Davies, Eleri; Wade, Phillip; Williams, Rachel; Copas, Andrew; Cutino-Moguel, Maria-Teresa; Freemantle, Nick; Hayward, Andrew C; Holmes, Alison; Hughes, Joseph; Mahungu, Tabitha; Nebbia, Gaia; Partridge, David; Pope, Cassie; Price, James; Robson, Samuel; Saeed, Kordo; de Silva, Thushan; Snell, Luke; Thomson, Emma; Witney, Adam A; Breuer, Judith.
Afiliación
  • Stirrup O; Institute for Global Health, University College London, London, UK oliver.stirrup@ucl.ac.uk.
  • Boshier F; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Venturini C; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Guerra-Assunção JA; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Alcolea-Medina A; Department of Genetics & Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Beckett A; Centre for Clinical Infection and Diagnostics Research, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Charalampous T; Infection Sciences, Viapath, London, UK.
  • da Silva Filipe A; Centre for Enzyme Innovation, University of Portsmouth, Portsmouth, UK.
  • Glaysher S; School of Biological Sciences, University of Portsmouth, Portsmouth, UK.
  • Khan T; Centre for Clinical Infection and Diagnostics Research, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Kulasegaran Shylini R; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Kele B; Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
  • Monahan I; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Mollett G; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Parker M; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Pelosi E; Institute for Infection and Immunity, St George's University of London, London, UK.
  • Randell P; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Roy S; Sheffield Bioinformatics Core, The University of Sheffield, Sheffield, UK.
  • Taylor J; Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK.
  • Weller S; Sheffield Biomedical Research Centre, The University of Sheffield, Sheffield, UK.
  • Wilson-Davies E; Southampton Specialist Virology Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Wade P; Department of Infection and Immunity, North West London Pathology, London, UK.
  • Williams R; Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Copas A; Southampton Specialist Virology Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Cutino-Moguel MT; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Freemantle N; The Florey Institute for Host-Pathogen Interactions & Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
  • Hayward AC; Department of Genetics & Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Mahungu T; Institute for Global Health, University College London, London, UK.
  • Nebbia G; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Partridge D; Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Pope C; Institute of Epidemiology and Health Care, University College London, London, UK.
  • Price J; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
  • Robson S; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Saeed K; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • de Silva T; Department of Virology, Royal Free London NHS Foundation Trust, London, UK.
  • Snell L; Centre for Clinical Infection and Diagnostics Research, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Thomson E; Department of Infectious Diseases, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Witney AA; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Breuer J; The Florey Institute for Host-Pathogen Interactions & Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
BMJ Open Respir Res ; 8(1)2021 09.
Article en En | MEDLINE | ID: mdl-34544733
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: BMJ Open Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: BMJ Open Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido